Here’s Why NuVasive Jumped 11.3% in October
Shares of NuVasive (NASDAQ: NUVA) added 11.3% in October, according to data provided by S&P Global Market Intelligence, after the spine technology company reported strong third-quarter results and increased its 2019 guidance.
Revenue increased 7.2% year over year, led by a 9.5% jump in sales of spinal hardware in the U.S. And that's factoring in a currency headwind. On a constant-currency basis, revenue would have been up 7.5%.
Sales of the XLIF and ALA hardware were boosted by Nuvasive's X360 lateral single-position procedure. The company noted that it had trained 20% more surgeons to do the procedure so far this year than it did in 2018.
Source Fool.com
